WORLDQUANT MILLENNIUM ADVISORS LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1745981
NEW YORK, NY
Position in BMY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$205,730,501
+$88,703,356 QoQ
Shares Held
3,392,094
+56.3% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $740,904,213 across 7 Drug Manufacturers - General names. BMY ranks #2 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
331,823 | $305,200,840 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
3,392,094 | $205,730,501 | |
| 3 | ABBV |
AbbVie Inc.
|
536,277 | $116,634,884 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
429,035 | $59,794,607 | |
| 5 | AMGN |
Amgen Inc
|
95,027 | $33,435,249 | |
| 6 | AZN |
Astrazeneca PLC
|
100,830 | $19,885,692 | |
| 7 | JNJ |
Johnson & Johnson
|
910 | $222,440 |
All Filings in BMY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,730,501 | 3,392,094 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $117,027,145 | 2,169,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $142,580,944 | 3,161,440 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $903,025 | 19,508 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,390,919 | 563,878 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $28,646,161 | 553,656 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,484,582 | 300,616 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $38,996,267 | 760,013 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $32,732,296 | 563,961 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,729,212 | 527,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $48,514,574 | 699,965 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,398,768 | 75,035 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $2,836,449 | 36,837 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $17,182,206 | 235,276 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $35,764,022 | 573,601 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,578,884 | 364,693 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,903,944 | 477,461 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $40,722,448 | 645,057 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,678,601 | 575,183 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $34,677,783 | 575,183 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $22,207,878 | 377,685 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,171,752 | 236,307 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||